Brief: Cingulate Partners With Bend Bio To Manufacture Next-Gen ADHD Treatment, Advancing Commercial Readiness

Cingulate

17/09/2025 13:57

Sept 17 (Reuters) - Cingulate Inc CING.O:

CINGULATE SECURES EXCLUSIVE MANUFACTURING PARTNERSHIP WITH BEND BIO SCIENCES TO SUPPORT FUTURE COMMERCIALIZATION OF NEXT GENERATION ADHD TREATMENT

CINGULATE INC - BEND BIO SCIENCES TO MANUFACTURE CTX-1301 IN U.S. THROUGH 2028

CINGULATE INC: TO PURCHASE 100% OF CO'S OVERALL U.S. COMMERCIAL SUPPLY OF CTX-1301 FROM BEND

Source text: ID:nGNX2sqgj1

Further company coverage: CING.O

 ((Reuters.Briefs@thomsonreuters.com;))